Reply to the manuscript "A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse" by J.-Y. Blay et al. (original) (raw)

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.